Influenza-associated mortality in subtropical or tropical regions, particularly in developing countries, remains poorly quantified and often underestimated. We analyzed data in Thailand, a middle-income tropical country with good vital statistics and influenza surveillance data.
We obtained weekly mortality data for all-cause and three underlying causes of death (circulatory and respiratory diseases, and pneumonia and influenza), and weekly influenza virus data, from 2006 to 2011. A negative binomial regression model was used to estimate deaths attributable to influenza in two age groups (<65 and ≥65 years) by incorporating influenza viral data as covariates in the model.
From 2006 to 2011, the average annual influenza-associated mortality per 100 000 persons was 4·0 (95% CI: −18 to 26). Eighty-three percent of influenza-associated deaths occurred among persons aged > 65 years. The average annual rate of influenza-associated deaths was 0·7 (95% CI: −8·2 to 10) per 100 000 population for person aged <65 years and 42 (95% CI: −137 to 216) for person aged ≥ 65 years.
In Thailand, estimated excess mortality associated with influenza was considerable even during non-pandemic years. These data provide support for Thailand's seasonal influenza vaccination campaign. Continued monitoring of mortality data is important to assess impact.
The global burden of influenza is unknown but thought to be considerable. In 2008, the global estimate of influenza-associated severe acute lower respiratory illness in children <5 years was 1 million cases,
The exact burden of influenza morality is difficult to estimate, and the challenges in counting influenza-associated deaths include the following: testing of hospital patients for influenza (particularly in elderly persons) is uncommon, influenza is rarely specifically recorded on death certificates, and many deaths that may be causally related to influenza occur after virus can be detected. Therefore, estimation of influenza-associated deaths or hospitalizations often relies on statistical modeling rather than on direct measurement. Various methodological approaches have been used to estimate the excess deaths associated with the circulation of influenza virus in temperate region.
Estimating the burden of influenza mortality is important to help guide vaccination programs, evaluate the use of diagnostic tests and antiviral drugs, and plan for seasonal epidemics and future pandemics. In this analysis, we applied a negative binomial model to the weekly counts of deaths and viral data to explore the seasonal effect of influenza on mortality and provided estimates of excess mortality associated in Thailand by death category, age group, and influenza subtypes for the years 2006 through 2011.
Weekly electronic mortality data for years 2006 through 2011 were obtained from the Bureau of Policy and Strategy, Ministry of Public Health (MoPH), Thailand. Deaths were categorized into three groups based on codes from the International Classification of Diseases, Tenth Revision [ICD-10]: circulatory diseases (
In 2004, the National Institute of Health, MoPH launched the national influenza sentinel surveillance system to monitor virus circulation in patients with influenza-like illness presenting at outpatient clinics in 11 sites throughout Thailand.
Of all-cause deaths among person aged <65 and ≥65 years, ill-defined deaths (i.e., no cause listed) accounted for 25% (58% of these occurred in the community) and 54% (87% occurred in the community), respectively. To account for the high proportion of ill-defined cause of death, we reapportioned weekly ill-defined deaths by age (<65 and ≥65 years), and location (hospital and community) to the various categories (P&I, respiratory, circulatory). We first excluded the ill-defined deaths and calculated the proportion of deaths due to P&I, respiratory and circulatory among deaths recorded in-hospital by age (<65 and ≥65 years) under the assumption that the coding for an in-hospital death was more accurate than for a community death. This assumption is based on the knowledge that deaths occurring outside the hospital are recorded by non-medical, civil registrars and based on lay reports from relatives.
We created two separated databases, one without reapportioning the deaths and the other with reapportioning.
Meteorological parameters including weekly mean temperature and absolute humidity were obtained from the Thai Meteorological Department.
A negative binomial regression model was used to estimate deaths attributable to influenza in two age groups (<65 and ≥65 years) by incorporating influenza viral data as covariates in the model. To assume an additive relationship between the exposure to influenza and resulting mortality, we used an identity link function in the models. The models included independent variables that comprised weekly percentage of specimens testing of confirmed infection with seasonal influenza A, seasonal influenza B, and influenza A (H1N1) pdm09 during a given week. We tested various lags (no lag, 1 week, and 2 weeks) to account for delays between infection and death. To account for the baseline, the models include either harmonic terms for annual [sine (θ) and cosine (θ), where θ = 2*π*week/52·25] and semiannual [sine (2θ) and cosine (2θ)] periods or climate factors [weekly mean temperature and absolute humidity, using linear terms or nonlinear terms (natural cubic spline function)]. Selection of the most statistically meaningful proxy for influenza activity was based on fitting 13 models to ≥65 years respiratory deaths and comparing Akaike information criterion (AIC) values. We obtained the smallest AIC values for a model with a 2-week lag and smoothing spline of temperature and humidity and report those results. A detailed description of the model fitting procedure is provided in Table S1.
In this model,
To estimate excess mortality associated with influenza, we used the following procedure:
Calculate the expected mortality with the full model (E0).
Calculate expected mortality with the same fitted model, but the influenza terms were set as zero (E1).
E0–E1 was the estimate of mortality due to influenza.
Confidence intervals were calculated based on the standard errors of model coefficients. We note that these confidence intervals provide only a minimum estimate of uncertainty.
The statistical analyses were carried out using
As a sensitivity analysis, we modeled all-cause deaths. We compared the excess deaths obtained using the all-cause deaths as outcome in the final models with estimates using respiratory and circulatory deaths as outcomes in the same models.
From January 2006 to December 2011, an annual mean of 399 853 deaths (range, 389 696 in 2006 to 413 209 in 2011) occurred in Thailand (42% occurred in hospital). An average of 13 554 (3·4%) underlying P&I deaths, 27 268 (6·8%) underlying respiratory deaths, and 37 112 (9·3%) underlying circulatory deaths occurred each year. Table
Average annual number and proportion of deaths by cause of death, location of death, and age group in Thailand, 2006–2011
| Cause of death | Total | In-hospital deaths (42%) | Community deaths (58%) | ||||
|---|---|---|---|---|---|---|---|
| <65 years (55%) | ≥65 years (45%) | All ages | <65 years (40%) | ≥65 years (60%) | All ages | ||
| Annual average number of deaths | 399 853 | 92 178 | 75 962 | 168 139 | 92 519 | 139 195 | 231 714 |
| Proportion of deaths | |||||||
| Respiratory disease | 27 268 (6·8) | 7481 (8·1) | 12 361 (16) | 19 842 (12) | 3575 (3·9) | 3851 (2·8) | 7426 (3·2) |
| Pneumonia and influenza | 13 554 (3·4) | 4583 (5·0) | 7279 (9·6) | 11 861 (7·1) | 935 (1·0) | 757 (0·5) | 1693 (0·7) |
| Circulatory disease | 37 113 (9·3) | 11 118 (12) | 14 482 (19) | 25 600 (15) | 5634 (6·1) | 5879 (4·2) | 11 513 (5·0) |
| Ill-defined | 163 474 (41) | 19 513 (21) | 14 615 (19) | 34 128 (20) | 27 194 (29) | 102 152 (73) | 129 345 (56) |
During the 6-year period, 21 560 specimens were tested for influenza viruses. There were 2961 (14%) positive results for influenza viruses. The annual mean number of tests positive was 14% (range 10–18%) for influenza A viruses, and 6·5% (range 4·1–10%) for influenza B viruses (Table S2).
For all ages combined, there was year-to-year variability in the annual number of influenza-associated deaths; the mean for all years was 2511 (4·0 per 100 000) (Table
Estimated annual influenza-associated deaths in Thailand, 2006–2011 (with the apportioned ill-defined deaths)
| Year | A(H1N1) | A(H3N2) | Pdm09 H1N1 | B | Total | Rate per 100 000 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Death | 95%CI | Death | 95%CI | Death | 95%CI | Death | 95%CI | Death | 95%CI | Rate | 95%CI | |||||||
| All age | ||||||||||||||||||
| 2006 | 625 | −3232 | 4151 | 228 | −3467 | 3922 | 0 | 0 | 0 | 647 | −3060 | 4328 | 1500 | −10 351 | 12 993 | 2·4 | −17 | 21 |
| 2007 | 215 | −3400 | 3710 | 1866 | −1690 | 5426 | 0 | 0 | 0 | 928 | −2655 | 4470 | 2952 | −8308 | 14 169 | 4·7 | −13 | 23 |
| 2008 | 642 | −3206 | 4143 | 1563 | −2115 | 5240 | 0 | 0 | 0 | 1499 | −2206 | 5150 | 3534 | −8101 | 15 107 | 5·6 | −13 | 24 |
| 2009 | 261 | −3759 | 4137 | 633 | −3299 | 4576 | 841 | −3601 | 4278 | 356 | −3593 | 4289 | 1524 | −14 252 | 17 280 | 2·4 | −22 | 27 |
| 2010 | 3 | −4266 | 4271 | 776 | −3491 | 5045 | 955 | −3884 | 4647 | 1078 | −3219 | 5312 | 2239 | −14 860 | 19 275 | 3·5 | −23 | 30 |
| 2011 | 0 | −4246 | 4246 | 2273 | −1965 | 6520 | 133 | −4189 | 4299 | 985 | −3281 | 5216 | 3315 | −13 681 | 20 281 | 5·2 | −21 | 32 |
| Average | 291 | −3685 | 4110 | 1223 | −2671 | 5122 | 643 | −3891 | 4408 | 916 | −3002 | 4794 | 2511 | −11 592 | 16 518 | 4·0 | −18 | 26 |
| Average (non-pandemic years) | 297 | −3670 | 4104 | 1341 | −2546 | 5231 | 544 | −4037 | 4473 | 1027 | −2884 | 4895 | 2708 | −11 060 | 16 365 | 4·3 | −17 | 26 |
| Aged ≤ 65 years | ||||||||||||||||||
| 2006 | 192 | −1251 | 1471 | 25 | −1337 | 1389 | 0 | 0 | 0 | 118 | −1250 | 1474 | 335 | −4430 | 4926 | 0·6 | −7·7 | 8·5 |
| 2007 | 66 | −1262 | 1332 | 214 | −1088 | 1512 | 0 | 0 | 0 | 172 | −1143 | 1460 | 395 | −4056 | 4867 | 0·7 | −7·0 | 8·4 |
| 2008 | 200 | −1222 | 1445 | 180 | −1158 | 1514 | 0 | 0 | 0 | 275 | −1076 | 1599 | 485 | −4030 | 5132 | 0·8 | −6·9 | 8·8 |
| 2009 | 81 | −1395 | 1487 | 72 | −1361 | 1509 | 678 | −1009 | 1860 | 66 | −1377 | 1500 | 330 | −5142 | 6356 | 0·6 | −8·8 | 11 |
| 2010 | 1 | −1547 | 1548 | 88 | −1458 | 1639 | 769 | −1065 | 2030 | 198 | −1362 | 1732 | 483 | −5432 | 6949 | 0·8 | −9·3 | 12 |
| 2011 | 0 | −1515 | 1515 | 259 | −1250 | 1776 | 109 | −1443 | 1581 | 179 | −1341 | 1685 | 471 | −5549 | 6557 | 0·8 | −9·4 | 11 |
| Average | 90 | −1365 | 1466 | 140 | −1275 | 1557 | 519 | −1172 | 1824 | 168 | −1258 | 1575 | 417 | −4773 | 5798 | 0·7 | −8·2 | 10 |
| Average (non-pandemic years) | 92 | −1359 | 1462 | 153 | −1258 | 1566 | 293 | −836 | 1204 | 188 | −1234 | 1590 | 434 | −4699 | 5686 | 0·7 | −8·0 | 10 |
| Aged 65+ years | ||||||||||||||||||
| 2006 | 433 | −1981 | 2680 | 203 | −2130 | 2533 | 0 | 0 | 0 | 529 | −1810 | 2854 | 1165 | −5921 | 8067 | 25 | −125 | 170 |
| 2007 | 149 | −2138 | 2378 | 1652 | −602 | 3914 | 0 | 0 | 0 | 756 | −1512 | 3010 | 2557 | −4252 | 9302 | 53 | −89 | 194 |
| 2008 | 442 | −1984 | 2698 | 1383 | −957 | 3726 | 0 | 0 | 0 | 1224 | −1130 | 3551 | 3049 | −4071 | 9975 | 63 | −84 | 206 |
| 2009 | 180 | −2364 | 2650 | 561 | −1938 | 3067 | 163 | −2592 | 2418 | 290 | −2216 | 2789 | 1194 | −9110 | 10 924 | 24 | −184 | 221 |
| 2010 | 2 | −2719 | 2723 | 688 | −2033 | 3406 | 186 | −2819 | 2617 | 880 | −1857 | 3580 | 1756 | −9428 | 12 326 | 35 | −185 | 242 |
| 2011 | 0 | −2731 | 2731 | 2014 | −715 | 4744 | 24 | −2746 | 2718 | 806 | −1940 | 3531 | 2844 | −8132 | 13 724 | 54 | −155 | 261 |
| Average | 201 | −2320 | 2643 | 1084 | −1396 | 3565 | 124 | −2719 | 2584 | 748 | −1744 | 3219 | 2094 | −6819 | 10 720 | 42 | −137 | 216 |
| Average (non-pandemic years) | 205 | −2311 | 2642 | 1188 | −1287 | 3665 | 105 | −2783 | 2668 | 839 | −1650 | 3305 | 2274 | −6361 | 10 679 | 46 | −128 | 215 |
Average for non-pandemic years (excluded 2009).
Three-year average.
Annual estimated number and rate of influenza-associated deaths for underlying P&I, respiratory, and circulatory deaths in Thailand, 2006–2011 (with the apportioned ill-defined deaths)
| Cause of death | Influenza | |||||
|---|---|---|---|---|---|---|
| Number of deaths | 95% CI | Rate per 1 000 000 | 95% CI | |||
| Respiratory disease | ||||||
| <65 years | 657 | −1788 | 3101 | 1·1 | −0·3 | 5·3 |
| ≥65 years | 2094 | −4611 | 8801 | 42 | −93 | 178 |
| All ages | 2751 | −6400 | 11 902 | 4·3 | −10·1 | 19 |
| Pneumonia and influenza | ||||||
| <65 years | 370 | −1256 | 2007 | 0·6 | −2·2 | 3·4 |
| ≥65 years | 1031 | −3201 | 5259 | 21 | −64·7 | 106 |
| All ages | 1401 | −4457 | 7266 | 2·2 | −7·0 | 11 |
| Circulatory disease | ||||||
| <65 years | 0 | −3363 | 3075 | 0·0 | −5·8 | 5·3 |
| ≥65 years | 529 | −5934 | 6797 | 11 | −120 | 138 |
| All ages | 529 | −9297 | 9871 | 0·8 | −14·7 | 16 |
The average annual rate of influenza-associated deaths for adults aged ≥65 years was 21 per 100 000 persons for P&I deaths, 42 per 100 000 for respiratory deaths, and 11 per 100 000 for circulatory deaths (Table
Weekly observed and predicted influenza-associated deaths from underlying P&I and respiratory and circulatory diseases (with the reapportioned ill-defined deaths).
Estimated mean annual influenza-associated deaths without reapportioning ill-defined death are shown in Table S3. The average annual number of influenza-associated deaths from underlying P&I, respiratory, and circulatory diseases was 632 (1·0 per 100 000), 1308 (2·1 per 100 000), and 295 (0·5 per 100 000, Table S4), respectively. The estimated number of influenza deaths from the model with reapportioned ill-defined deaths and from the non-reapportion model for persons aged <65 was similar, while for those age ≥ 65 years, the estimates from reapportioned models were approximately 3 times higher than from the non-reapportion model. Compared with Figure
Influenza was associated with excess death in Thailand, and the estimated excess mortality was considerable (average 4·0 per 100 000 persons), with 83% of the influenza-associated deaths among persons ≥65 years. The estimated annual excess morality in persons ≥65 years was 42 per 100 000 persons. These finding are similar, but slightly lower than those from a recent study in Thailand that used a Bayesian model to estimate excess mortality due to seasonal influenza; this study found an estimated 6·1 annual excess deaths per 100 000 population and 68 per 100 000 among person ≥60 years.
Our estimates of annual influenza-associated underlying P&I, underlying respiratory and underlying circulatory deaths in Thailand for the all-ages group were two times lower than the estimates of excess influenza deaths observed in tropical Singapore,
Although there were peaks in influenza-associated mortality in Thailand during 2006 through 2011, they were not consistent in their timing. This is in contrast to trends observed in temperate climates and likely reflects the year-round circulation of influenza viruses which may attenuate any seasonal mortality pattern. The majority of deaths from seasonal influenza occurred among people aged 65 year or older, but in the pandemic, the proportion of deaths among younger persons increased. This may suggest that there was some immunologic protection in persons who were exposed to A(H1N1) viruses before the 1957 pandemic, as has been demonstrated in other countries.
Our estimates of influenza-associated deaths have several methodological limitations. First, the quality of mortality statistics in Thailand was considered poor because a large proportion had a poorly defined cause of death.
These data are important to help guide the introduction of prevention strategies, such as seasonal influenza vaccination. Despite the widespread adoption of seasonal influenza vaccine recommendations in middle-income countries that have sufficient economic and public health resources to support vaccination programs, in Thailand seasonal influenza vaccine has been administered to <1% of the population annually and does not meet the need of the identified target groups.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention or the Thailand Ministry of Public Health.